1. Home
  2. PTCT vs RUN Comparison

PTCT vs RUN Comparison

Compare PTCT & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • RUN
  • Stock Information
  • Founded
  • PTCT 1998
  • RUN 2007
  • Country
  • PTCT United States
  • RUN United States
  • Employees
  • PTCT N/A
  • RUN N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • RUN Industrial Machinery/Components
  • Sector
  • PTCT Health Care
  • RUN Miscellaneous
  • Exchange
  • PTCT Nasdaq
  • RUN Nasdaq
  • Market Cap
  • PTCT 5.3B
  • RUN 3.7B
  • IPO Year
  • PTCT 2013
  • RUN 2015
  • Fundamental
  • Price
  • PTCT $74.86
  • RUN $19.32
  • Analyst Decision
  • PTCT Buy
  • RUN Buy
  • Analyst Count
  • PTCT 17
  • RUN 19
  • Target Price
  • PTCT $73.24
  • RUN $20.41
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • RUN 8.3M
  • Earning Date
  • PTCT 11-04-2025
  • RUN 11-06-2025
  • Dividend Yield
  • PTCT N/A
  • RUN N/A
  • EPS Growth
  • PTCT N/A
  • RUN N/A
  • EPS
  • PTCT 8.94
  • RUN N/A
  • Revenue
  • PTCT $1,779,150,000.00
  • RUN $2,316,656,000.00
  • Revenue This Year
  • PTCT $119.02
  • RUN $11.35
  • Revenue Next Year
  • PTCT N/A
  • RUN $9.26
  • P/E Ratio
  • PTCT $8.37
  • RUN N/A
  • Revenue Growth
  • PTCT 97.54
  • RUN 13.79
  • 52 Week Low
  • PTCT $35.95
  • RUN $5.38
  • 52 Week High
  • PTCT $75.82
  • RUN $22.44
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 77.19
  • RUN 49.46
  • Support Level
  • PTCT $69.23
  • RUN $15.92
  • Resistance Level
  • PTCT $73.98
  • RUN $20.20
  • Average True Range (ATR)
  • PTCT 2.65
  • RUN 1.40
  • MACD
  • PTCT 0.37
  • RUN -0.22
  • Stochastic Oscillator
  • PTCT 89.10
  • RUN 60.04

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

Share on Social Networks: